|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Cash from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Credit loss expense | ||||
| Depreciation | ||||
| Amortization of intangible assets | ||||
| Impairment of long-lived assets | ||||
| Impairment of right-of-use assets | ||||
| Future stay credit breakage | ||||
| Reduction in the carrying amount of right-of-use assets | ||||
| Deferred income taxes | ||||
| Other gains and losses | ||||
| Fair value adjustment on derivative liabilities | ||||
| Fair value adjustment on financial instruments remeasured at fair value through earnings | ||||
| Convertible Notes and Notes Option issuance costs expensed as incurred | ||||
| Non-cash interest expense | ||||
| Equity-based compensation expense | ||||
| Change in operating assets and liabilities, net of assets acquired and liabilities assumed: | ||||
| Accounts receivable | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable | ||||
| Funds payable to owners | ||||
| Hospitality and sales taxes payable | ||||
| Deferred revenue and future stay credits | ||||
| Operating lease obligations | ||||
| Accrued expenses and other liabilities | ||||
| Net cash used in operating activities | ||||
| Cash from investing activities: | ||||
| Purchases of property and equipment | ||||
| Cash paid for internally developed software | ||||
| Cash paid for business combinations, net of cash and restricted cash acquired | ||||
| Other investing activities | ||||
| Net cash used in investing activities | ||||
| Cash from financing activities: | ||||
| Proceeds from Reverse Recapitalization, net | ||||
| Payments of Reverse Recapitalization costs | ||||
| Cash paid for business combinations | ||||
| Cash paid for issuance costs from Convertible Notes and Notes Option | ||||
| Payments of long-term debt | ||||
| Proceeds from exercise of stock options | ||||
| Proceeds from issuance of preferred units, net of issuance costs | ||||
| (Payments to) proceeds from Employee Stock Purchase Program, net of refunds | ||||
| Proceeds from borrowings on revolving credit facility | ||||
| Proceeds from borrowings on Convertible Notes and Notes Option | ||||
| Repayment of borrowings on revolving credit facility | ||||
| Repayment of financed insurance premiums | ||||
| Other financing activities | ||||
| Net cash provided by (used in) financing activities | ||||
| Effect of exchange rate fluctuations on cash, cash equivalents, and restricted cash | ||||
| Net decrease in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash, beginning of period | ||||
| Cash, cash equivalents and restricted cash, end of period | ||||
| Supplemental disclosures of cash flow information: | ||||
| Cash paid for income taxes, net of refunds | ||||
| Cash paid for interest | ||||
| Cash paid for operating lease liabilities | ||||
| Supplemental disclosures of non-cash activities: | ||||
| Financed insurance premiums | ||||
| Issuance of common units for consideration in a business combination | ||||
| Issuance of common stock in connection with conversion of D-1 Notes (See Note 10, Debt) | ||||
| Lease liabilities exchanged for right-of-use assets | ||||
| Issuance of Class A Common Stock for Convertible Notes | ||||
| Reconciliation of cash, cash equivalents and restricted cash: | ||||
| Cash and cash equivalents | ||||
| Restricted cash | ||||
Loading...